Cargando…
Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer
Tumor microenvironment (TME) consists of several immune and nonimmune cell populations including tumor cells. For many decades, experimental studies have depicted profound contribution of TME toward cancer progression and metastasis development. Several therapeutic strategies have been tested agains...
Autores principales: | Achyut, Bhagelu R, Arbab, Ali S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780185/ https://www.ncbi.nlm.nih.gov/pubmed/27042097 http://dx.doi.org/10.2147/OTT.S102907 |
Ejemplares similares
-
Delineating Pro-Angiogenic Myeloid Cells in Cancer Therapy
por: Johnson, Benjamin W., et al.
Publicado: (2018) -
Cancer Therapeutics Following Newton’s Third Law
por: Arbab, Ali S., et al.
Publicado: (2016) -
Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis
por: Borin, Thaiz F., et al.
Publicado: (2017) -
Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma
por: Arbab, Ali S., et al.
Publicado: (2017) -
Critical immunosuppressive effect of MDSC-derived exosomes in the tumor microenvironment
por: Rashid, Mohammad H., et al.
Publicado: (2021)